As of 2026-02-07, the EV/EBITDA ratio of Revolution Medicines Inc (RVMD) is -29.51. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. RVMD's latest enterprise value is 18,885.83 mil USD. RVMD's TTM EBITDA according to its financial statements is -639.94 mil USD. Dividing these 2 quantities gives us the above RVMD EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |
| 2026-02-02 | -29.41 |
| 2026-01-30 | -29.35 |
| 2026-01-29 | -29.73 |
| 2026-01-28 | -29.46 |
| 2026-01-27 | -30.22 |
| 2026-01-26 | -29.60 |
| 2026-01-23 | -35.60 |
| 2026-01-22 | -35.95 |
| 2026-01-21 | -35.57 |
| 2026-01-20 | -35.17 |
| 2026-01-16 | -36.40 |
| 2026-01-15 | -37.30 |
| 2026-01-14 | -36.68 |
| 2026-01-13 | -36.30 |
| 2026-01-12 | -35.46 |
| 2026-01-09 | -35.90 |
| 2026-01-08 | -32.50 |
| 2026-01-07 | -31.09 |
| 2026-01-06 | -24.18 |
| 2026-01-05 | -23.72 |
| 2026-01-02 | -23.93 |
| 2025-12-31 | -24.12 |
| 2025-12-30 | -24.13 |
| 2025-12-29 | -24.39 |
| 2025-12-26 | -24.45 |
| 2025-12-24 | -24.59 |
| 2025-12-23 | -24.31 |
| 2025-12-22 | -24.40 |
| 2025-12-19 | -23.86 |
| 2025-12-18 | -23.01 |
| 2025-12-17 | -23.24 |
| 2025-12-16 | -23.49 |
| 2025-12-15 | -23.93 |
| 2025-12-12 | -23.90 |
| 2025-12-11 | -23.78 |
| 2025-12-10 | -23.59 |
| 2025-12-09 | -23.57 |
| 2025-12-08 | -24.25 |
| 2025-12-05 | -24.12 |
| 2025-12-04 | -23.77 |
| 2025-12-03 | -23.53 |
| 2025-12-02 | -22.81 |
| 2025-12-01 | -22.96 |
| 2025-11-28 | -23.55 |
| 2025-11-26 | -23.50 |
| 2025-11-25 | -23.12 |
| 2025-11-24 | -22.31 |
| 2025-11-21 | -21.47 |
| 2025-11-20 | -21.17 |
| 2025-11-19 | -21.37 |